- Exchange: NYSE MKT LLC
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Navidea Biopharmaceuticals Inc
+ Add to WatchlistNAVB:US
2.5000 USD 0.0500 2.04%As of 20:04:02 ET on 05/21/2013.
Company Profile for Navidea Biopharmaceuticals Inc (NAVB)
Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.
Contact Information
Navidea Biopharmaceuticals Inc
425 Metro Place North
Suite 300
Dublin, OH 43017-1367
United States
Key Executives for Navidea Biopharmaceuticals Inc (NAVB)
| Mark Jerome PykettChief Executive Officer | Thomas H Tulip "Thom"President/Chief Business Ofcr |
| Cornelia B ReiningerSenior VP/Chief Medical Officer | Brent L LarsonExec VP/CFO |
| Rodger A BrownVP:Regulatory Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page